Keywords

Bone cancer

Breast Cancer

General Oncology

Gynecological Cancers

Head and neck cancer

Lung Cancer

Radiation Oncology

The Effect of Eupalinolide B on AmyotrophicLateral Sclerosis : A Case Report

Authors:

Huaixiu Wang

Shanxi Provincal Hospital, Taiyuan, Shanxi Province, China

Correspondence to Author: Huaixiu Wang

Abstract:

Objective: To investigate the effect of Eupalinolide B (EB) on amyotrophic lateral sclerosis (ALS).
Method: EB was administered 20 mg/d orally for one month. Muscular tension,muscular strength and neural reflexes etc.before and after experiment were compared.
Results: After EB administration the abnormally lower muscular tension and muscular strength
were improved. Ankle clonus disappeared. Amyotrophic lateral sclerosis function rating system revised (ALSFRS-R) stopped worsening. But 10 days after discontinuation of EB, the above improvements disappeared gradually.
Discussion: EB might be effective on ALS and deserves further investigation

Keywords:

Eupalinolide B; amyotrophic lateral sclerosis; sesquiterpenes, Eupatorium Lindleyanum, Chinese herbs.

Citation:

Huaixiu Wang. The Effect of Eupalinolide B on AmyotrophicLateral Sclerosis : A Case Report. World Journal of Medical Oncology 2023

Journal Info

  • Journal Name: World Journal of Medical Oncology
  • Impact Factor: 2.709**
  • ISSN: 2766-6077
  • DOI: 10.52338/wjoncgy
  • Short Name: WJMOY
  • Acceptance rate: 55%
  • Volume: 6 (2024)
  • Submission to acceptance: 25 days
  • Acceptance to publication: 10 days

INDEXING

  • Crossref indexed journal impact factor of 2.980**
  • Publons indexed journal impact factor of 3.90**
  • Pubmed-indexed journal impact factor of 5.2**
  • International Scientific Indexing (ISI)-indexed journal impact factor of 2.980**
  • Eurasian Scientific Journal Index (ESJI) index journal impact factor of 2.980**
  • Semantic Scholar indexed journal impact factor of 2.980**
  • Cosmos indexed journal impact factor of 3.981**

OUR PUBLICATION BENEFITS

  • International Reach
  • Peer Review
  • Rapid Publication
  • Open Access
  • High Visibility